CAPLIPOINTUpdated 6 Sept 2026, 2:26

Caplin Point Lab Ltd.

CAPLIPOINTUpdated 6 Sept 2026, 2:26

Market Cap

₹21,365Cr.

Current Price

₹2,811

High / Low

₹2,877/1,500

Stock P/E

50.9

ROE20.4%

ROCE26.5%

Book Value₹270

Face Value₹2.00

Dividend Yield0.28%

About

Caplin Point Laboratories Ltd is engaged in the manufacturing and sourcing of APIs, finished formulations, R&D, clinical research with presence in Latin America, Africa, USA and other nations.[1]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios

Category	Jun 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	0	11	3	74	85	151	74	37	61	75	85	131
Inventory Days	36	56	50	58	36	34	47	76	95	153	102	137
Days Payable	108	161	149	148	92	79	131	116	130	140	93	148
Cash Conversion Cycle	-72	-94	-95	-16	30	107	-10	-2	26	89	93	120
Working Capital Days	-125	-112	-44	44	62	137	60	96	23	76	97	140
ROCE %	64%	60%	56%	58%	55%	48%	30%	29%	28%	29%	29%	26%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 6 September 2026 at 2:26

CAPLIN POINT LAB LTD. (CAPLIPOINT) financials — quarterly results, P&L, cash flow, balance sheet, shareholding